This Valuable COVID Treatment Doesn't Work against New Variants

Trouble viewing? View in your browser.
View all Scientific American publications.
    
January 03, 2023

Pharmaceuticals

A Valuable COVID Drug Doesn't Work against New Variants

Current monoclonal antibodies fail against COVID virus variants, so drugmakers want to use a fast-track test for new ones

By Charles Schmidt

Psychology

The Best New Year's Resolution Might Be to Just Let Go of an Unfulfilled Life Goal

Leaving aside a cherished objective may benefit psychological and even physical health

By Francine Russo

Climate Change

Financial Firms May Have to Reveal their Climate Risk

And public companies may have to disclose their greenhouse gas emissions, if regulators finalize proposed rules

By Avery Ellfeldt,E&E News

Animals

Storm-Chasing Seabirds Ride Out Hurricanes from Inside

Streaked shearwaters head deep into hurricanes to avoid crash landings

By Jesse Greenspan

Biochemistry

Lab-Made Motors Could Move and Glow in Cells

Minuscule motor molecules could emit light as they journey into cells

By Rachel Berkowitz

Psychology

Your Response to Stress Improves as You Grow Older

In good news, our reactions to stressful events improve as we age. But living in uncertain times will still take a toll

By Daisy Yuhas

Animals

Your Cats Can Tell When You're Speaking to Them

Felines recognize their owners' cat-directed baby talk

By Tanya Lewis

Microbiology

Electric Countdown Tells Sleeping Spores When to Wake Up

Do sleeping spores dream of electric sheep?

By Elise Cutts
FROM THE STORE
FROM THE ARCHIVE

Pandemic-Era Research Will Pay Off for Years

The COVID research infrastructure will help fight all sorts of pathogens

QUOTE OF THE DAY

"We're at a point now where we can say that the capacity to neutralize SARS-CoV-2 correlates with protection against COVID disease in the real world."

Robert Carnahan, a microbiologist at Vanderbilt University Medical Center.

WHAT WE'RE READING

Starting Off the New Year Without a Smartphone

Without being too sanctimonious about it.

By Christopher Schaberg | Slate | Jan. 1, 2023

LATEST ISSUES

Questions?   Comments?

Send Us Your Feedback
Download the Scientific American App
Download on the App Store
Download on Google Play

To view this email as a web page, go here.

You received this email because you opted-in to receive email from Scientific American.

To ensure delivery please add news@email.scientificamerican.com to your address book.

Unsubscribe     Manage Email Preferences     Privacy Policy     Contact Us

Comments

Popular Posts